Placebo Effect Clinical Trial
Official title:
Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size
Verified date | February 2016 |
Source | King Faisal Specialist Hospital & Research Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The total effect of a medication is the sum of its drug effect, placebo effect (meaning response of placebo), and their possible interaction. Current interpretation of the results of clinical trials (the gold standard in evidence based medicine) assumes no such interaction. Using a novel cross-over balanced placebo design and caffeine as a model drug, the investigators have recently shown that a negative interaction does exist; suggesting that the size of drug effect as currently measured by clinical trials may not be accurate. Due to the novelty of the findings and their important clinical practice and research implications, they need to be confirmed using another drug; and the size of drug effect measured using the novel design need to be directly compared to that measured using conventional clinical trial design. The results of the study are expected to further our understanding of a widely used medical intervention, i.e., placebo, and help assess the appropriateness of randomized clinical trials in determining the size of drug effect.
Status | Completed |
Enrollment | 480 |
Est. completion date | October 2015 |
Est. primary completion date | October 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Age of 18 to 50 years; - Being healthy, - Able to abstain from smoking and alcohol - Medication-free for one week - Able to reproducibly express oneself using a 100 mm visual analog scale (VAS). Exclusion Criteria: - clinically relevant deviation from normal health - pregnancy or lactation - hypersensitivity to hydroxyzine or related compounds |
Country | Name | City | State |
---|---|---|---|
Saudi Arabia | King Faisal Specialist Hospital & research Center | Riyadh |
Lead Sponsor | Collaborator |
---|---|
King Faisal Specialist Hospital & Research Center |
Saudi Arabia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Area-under-the-curve for drowsiness | Seven-hour-area-under-the-curve of drowsiness on 100 mm visual analog scales will be determined | seven hours | |
Primary | Area-under-the-curve for dryness of the mouth | Seven-hour-area-under-the-curve of dryness of the mouth on 100 mm visual analog scales will be determined | seven hours | |
Secondary | Mean percent of time of reporting drowsiness on a dichotomous scale. | Mean percent of time of reporting drowsiness on a dichotomous scale will also be determined. | seven hours | |
Secondary | Mean percent of time of reporting dryness of mouth | Mean percent of time of reporting dryness of mouth on a dichotomous scale will also be determined. | seven hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04650841 -
The Role of the Opioid System in Placebo Effects on Pain and Social Rejection
|
Early Phase 1 | |
Completed |
NCT03694886 -
The Effect of Tablet Size on Cognitive Performance Caffeine
|
Phase 4 | |
Not yet recruiting |
NCT04646460 -
Context Interventions: Social Modeling and Initial Treatment Experience
|
N/A | |
Completed |
NCT04571827 -
The Influence of Expectations on Post-needling Soreness and Pain Processing After Dry Needling Treatment
|
N/A | |
Completed |
NCT02802241 -
Effects of Open-label vs Double-blind Treatment in IBS
|
N/A | |
Not yet recruiting |
NCT06423365 -
A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.
|
N/A | |
Completed |
NCT03017534 -
Non-Specific Effects of Manual Therapy
|
N/A | |
Completed |
NCT02578420 -
Back to Basics - Effects, Narratives and Routes of Administration of Open-label Placebo
|
N/A | |
Completed |
NCT02578212 -
Trust Game and Placebo Response
|
N/A | |
Completed |
NCT00426010 -
Measuring Placebo Effect by Elimination and Investigating Mechanism of Action
|
N/A | |
Completed |
NCT02365220 -
Smartphone Application, Mood and Stress
|
N/A | |
Completed |
NCT01501747 -
The Placebo Effect May Involve Modulating Drug Bioavailability
|
N/A | |
Recruiting |
NCT04766580 -
Attention and Pain in Children With and Without Attention Deficit and/or Hyperactivity Disorder
|
N/A | |
Completed |
NCT05004467 -
Clinical Predictive Effects of Mulligan Treatment in Patients With Chronic Neck Pain
|
N/A | |
Recruiting |
NCT03950999 -
Experimental Pain Reporting Accuracy and Placebo Response
|
N/A |